European P&C stocks suffer worst year since financial crisisEuropean P&C stocks suffered their worst year since the 2008 financial crisis despite a fourth-quarter rally as the Covid-19 pandemic and Brexit uncertainty hit stocks during a turbulent 12 months for sector investors.
London P&C stocks gain in first session since Brexit trade deal and US stimulus billLondon-listed (re)insurance stocks rose sharply this morning as the UK’s blue-chip benchmark looks set to hit its highest level since early March in the first session since the post-Brexit trade deal was confirmed and news of a fresh $900bn stimulus bill in the US.
R&Q founders sell down stakesAlan Quilter, CEO of London-listed Randall & Quilter Investment Holdings Ltd (R&Q), has sold 400,000 shares in the firm netting £700,000, according to a 21 December regulatory disclosure with the London Stock Exchange.
Markets Review: Brexit fears push Euro P&C stocks lowerEuropean (re)insurance equities closed lower last week to end five straight weeks of gains as a fresh wave of investor jitters set in on the rapidly approaching deadline for Brexit negotiations.
Conduit Re outperforms London-listed peers on LSE debutShares in newly floated reinsurance start-up Conduit Re closed lower on their London debut but outperformed London-listed peers in a choppy day for European insurance equities.
Markets Review: Mapfre led gains in muted week for Euro P&C stocksShares in Spanish (re)insurer Mapfre gained over 8 percent in an otherwise muted week of trading for European P&C stocks amid investor caution over Brexit negotiations and new coronavirus measures.
European P&C stocks dip on Brexit tensionsEuropean (re)insurance stocks edged lower on Thursday after a record finish in the US, as Brexit tensions and trade uncertainty dented investor optimism.
Conduit floats on LSE in £826mn IPOConduit has raised £826mn ($1.1bn) in its initial public offering on the London Stock Exchange (LSE), meeting its targeted capital to begin writing business at 1 January.
Markets Review: Kinsale leads gains in record November rallyShares in excess and surplus lines specialist Kinsale Capital Group surged 28.1 percent in November to lead widespread gains amongst US P&C stocks as Wall Street posted its best monthly performance in three decades.
Markets Review: RSA adds 59% in November global vaccine-led rallyShare’s in London-listed RSA gained almost 60 percent in November as UK and European stocks closed their best month in more than three decades, after a rally powered by Covid-19 vaccine breakthroughs.
Markets Review: UK P&C stocks underperform as Euro peers make fourth weekly gainLondon-listed (re)insurance stocks closed in the red last week, bringing an end to almost a month of solid gains as UK equities underperformed their continental peers, in part driven by worries over a new vaccine and renewed investor jitters over Brexit.
US P&C stocks rise as Dow hits record high on Covid vaccines and presidential transitionUS property casualty insurance stocks rallied on Tuesday in line with the wider financial markets in response to further positive news regarding coronavirus vaccinations and a seemingly smoother transition to the next president.
Root’s share price drops 10% after analysts initiate coverageThe share price of newly-floated Root dropped over 10 percent on Monday after equity analysts initiated coverage, with some questioning how long it will take the motor insurtech to reach profitability.
Markets Review: Euro P&C stocks register third straight week of gainsEuropean (re)insurance stocks clocked their third straight week of gains last week and remain on track for one of their strongest monthly rallies on record as most sectors and major indices continued to advance on the prospect of an effective coronavirus vaccine.
Analysts remain bullish on Palomar despite cat frequency challenged Q3Palomar shares traded down sharply last week in response to Q3 earnings that included a significant impact from frequency losses, but analysts from KBW and JMP Securities remain bullish on the stock after the US specialty insurer took swift action to shrink net catastrophe exposure.
US P&C stocks rally as Dow hits record high on Covid vaccine hopesUS-listed (re)insurance stock enjoyed large gains on Monday, led by Hallmark Financial and Third Point Re, as investors responded to further positive news about a potential Covid-19 vaccine.
US shares up on positive Moderna vaccine resultsWall Street stocks have climbed along with European P&C stocks following an announcement today from US drug firm Moderna that its coronavirus vaccine proved to be almost 95 percent effective in early testing.
Markets Review: Beazley shares leap as vaccine cheer persistsShares in London-listed Beazley surged over 20 percent last week to lead widespread gains for European P&C stocks as most sectors and major indices advanced on the prospect of an effective coronavirus vaccine.
Euro P&C stocks muted on virus cases and lockdown woesEuropean P&C stocks struggled for direction on Friday as investors weighed the worsening coronavirus pandemic against optimism about potential vaccines.
Activist Elliott builds Sampo stake and demands €7bn value creation measuresFeared shareholder activist hedge fund Elliott Advisors has called on Finnish-Scandinavian insurance group Sampo to simplify the organisation and “re-establish its reputation among shareholders”.